High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial (Q34562602)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial |
scientific article |
Statements
1 reference
High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial (English)
1 reference
John J P Kastelein
1 reference
Terje R Pedersen
1 reference
Ole Faergeman
1 reference
Anders G Olsson
1 reference
Matti J Tikkanen
1 reference
Ingar Holme
1 reference
Mogens Lytken Larsen
1 reference
Fredrik S Bendiksen
1 reference
Christina Lindahl
1 reference
Michael Szarek
1 reference
John Tsai
1 reference
Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group
1 reference
1 November 2005
1 reference
1 reference
Identifiers
1 reference